[Extended optic neuropathy with myelin oligodendrocyte glycoprotein antibodies].

Autor: Gillard F; Service d'Ophtalmologie, CHU Liège, Belgique., Andris C; Service de Neuro-Ophtalmologie, CHU Liège, Belgique., Lommers E; Service de Neurologie, CHU Liège, Belgique.

Publikováno v: Revue medicale de Liege [Rev Med Liege] 2019 Apr; Vol. 74 (4), pp. 179-184.

Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS.

Autor: Gerhards R; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Pfeffer LK; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Lorenz J; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Starost L; Institute of Neuropathology, University Hospital Münster, Münster, Germany., Nowack L; Institute of Neuropathology, University Hospital Münster, Münster, Germany., Thaler FS; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Schlüter M; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Rübsamen H; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Macrini C; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Winklmeier S; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Mader S; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Bronge M; Therapeutic Immune Design, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Grönlund H; Therapeutic Immune Design, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Feederle R; Institute for Diabetes and Obesity, Monoclonal Antibody Core Facility, Helmholtz Center Munich, German Research Center for Environmental Health (GmbH), Neuherberg, Germany., Hsia HE; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, German Center for Neurodegenerative Diseases (DZNE), Technical University of Munich, Munich, Germany., Lichtenthaler SF; Neuroproteomics, School of Medicine, Klinikum rechts der Isar, German Center for Neurodegenerative Diseases (DZNE), Technical University of Munich, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Merl-Pham J; Research Unit Protein Science, Helmholtz Center Munich, Munich, Germany., Hauck SM; Research Unit Protein Science, Helmholtz Center Munich, Munich, Germany., Kuhlmann T; Institute of Neuropathology, University Hospital Münster, Münster, Germany., Bauer IJ; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Beltran E; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Gerdes LA; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Mezydlo A; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Bar-Or A; Department of Neurology, University of Pennsylvania, Philadelphia, USA., Banwell B; Children's Hospital of Philadelphia, Philadelphia, USA., Khademi M; Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Olsson T; Neuroimmunology Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Hohlfeld R; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Lassmann H; Center for Brain Research, Medical University, Vienna, Austria., Kümpfel T; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Kawakami N; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany., Meinl E; Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, Großhaderner Str. 9, 82152, Planegg-Martinsried, Germany. edgar.meinl@med.uni-muenchen.de.

Publikováno v: Acta neuropathologica communications [Acta Neuropathol Commun] 2020 Nov 30; Vol. 8 (1), pp. 207. Date of Electronic Publication: 2020 Nov 30.

InCl 3 mediated heteroarylation of indoles and their derivatization via CH activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and/or multiple sclerosis.

Autor: Sunke R; Dr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500 046, India., Bankala R; Dr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500 046, India., Thirupataiah B; Dr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500 046, India; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Madhav Nagar, 576 104, Karnataka, India., Ramarao EVVS; Dr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500 046, India., Kumar JS; Dr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500 046, India., Doss HM; Immunopathology Lab, School of BioSciences and Technology, VIT University, Vellore, 632014, India., Medishetti R; Dr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500 046, India., Kulkarni P; Dr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500 046, India., Kapavarapu RK; Dr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500 046, India., Rasool M; Immunopathology Lab, School of BioSciences and Technology, VIT University, Vellore, 632014, India., Mudgal J; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Madhav Nagar, 576 104, Karnataka, India., Mathew JE; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Madhav Nagar, 576 104, Karnataka, India., Shenoy GG; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Madhav Nagar, 576 104, Karnataka, India., Parsa KVL; Dr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad 500 046, India. Electronic address: KishoreP@DRILS.ORG., Pal M; Immunopathology Lab, School of BioSciences and Technology, VIT University, Vellore, 632014, India. Electronic address: manojitpal@rediffmail.com.

Publikováno v: European journal of medicinal chemistry [Eur J Med Chem] 2019 Jul 15; Vol. 174, pp. 198-215. Date of Electronic Publication: 2019 Apr 16.

Confirmed enterovirus encephalitis with associated steroid-responsive acute disseminated encephalomyelitis: an overlapping infection and inflammation syndrome.

Autor: Pillai S; Neuroimmunology Group, Institute for Neuroscience and Muscle Research, Australia; TY Nelson Department of Neurology, the Children's Hospital at Westmead, Australia., Tantsis E; Neuroimmunology Group, Institute for Neuroscience and Muscle Research, Australia; TY Nelson Department of Neurology, the Children's Hospital at Westmead, Australia; Discipline of Paediatrics and Child Health, University of Sydney, Australia., Prelog K; Department of Radiology, the Children's Hospital at Westmead, Australia., Ramanathan S; Neuroimmunology Group, Institute for Neuroscience and Muscle Research, Australia; Discipline of Paediatrics and Child Health, University of Sydney, Australia., Webster R; TY Nelson Department of Neurology, the Children's Hospital at Westmead, Australia., Ouvrier RA; TY Nelson Department of Neurology, the Children's Hospital at Westmead, Australia., Kesson A; Department of Infectious Diseases and Microbiology, the Children's Hospital at Westmead, Australia; Discipline of Paediatrics and Child Health, University of Sydney, Australia; Marie Bashir Institute, University of Sydney, Australia., Brilot F; Neuroimmunology Group, Institute for Neuroscience and Muscle Research, Australia; Discipline of Paediatrics and Child Health, University of Sydney, Australia., Dale RC; Neuroimmunology Group, Institute for Neuroscience and Muscle Research, Australia; TY Nelson Department of Neurology, the Children's Hospital at Westmead, Australia; Discipline of Paediatrics and Child Health, University of Sydney, Australia. Electronic address: russell.dale@health.nsw.gov.au.

Publikováno v: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society [Eur J Paediatr Neurol] 2015 Mar; Vol. 19 (2), pp. 266-70. Date of Electronic Publication: 2014 Dec 24.

The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis.

Autor: Gharagozloo M; Program of Immunology, Department of Pediatrics, CR-CHUS, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada. Marjan.Gharagozloo@usherbrooke.ca., Mahvelati TM; Program of Immunology, Department of Pediatrics, CR-CHUS, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada. Tara.Mahvelati@usherbrooke.ca., Imbeault E; Program of Immunology, Department of Pediatrics, CR-CHUS, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada. Emilie.Imbeault@usherbrooke.ca., Gris P; Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada. pavel.gris@mcgill.ca., Zerif E; Program of Immunology, Department of Pediatrics, CR-CHUS, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada. Echarki.Zerif@USherbrooke.ca., Bobbala D; Program of Immunology, Department of Pediatrics, CR-CHUS, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada. Diwakar.Bobbala@USherbrooke.ca., Ilangumaran S; Program of Immunology, Department of Pediatrics, CR-CHUS, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada. Subburaj.Ilangumaran@USherbrooke.ca., Amrani A; Program of Immunology, Department of Pediatrics, CR-CHUS, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada. abdelaziz.amrani@usherbrooke.ca., Gris D; Program of Immunology, Department of Pediatrics, CR-CHUS, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec, Canada. Denis.Gris@usherbrooke.ca.

Publikováno v: Journal of neuroinflammation [J Neuroinflammation] 2015 Oct 31; Vol. 12, pp. 198. Date of Electronic Publication: 2015 Oct 31.